Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline and MMP-9 in Cardiovascular Function in Type 2 Diabetes
2015-002387-16Phase 2Completed
- Sponsor
- Solvotrin Therapeutics
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of minocycline in type 2 diabetes mellitus (T2DM), sponsored by Solvotrin Therapeutics. Primary endpoint: Change in serum MMP-9 level. Started Jul 2015; status: completed.
02
Drugs
minocycline
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-002387-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002387-16.